Biomarkers in Breast Cancer: Molecular Diagnostics for Predicting and Monitoring Therapeutic Effect (Cancer Drug Discovery and Development)

0 avg rating
( 0 ratings by Goodreads )
 
9781617374364: Biomarkers in Breast Cancer: Molecular Diagnostics for Predicting and Monitoring Therapeutic Effect (Cancer Drug Discovery and Development)
View all copies of this ISBN edition:
 
 

Expert laboratory and clinical researchers from around the world review how to design and evaluate studies of tumor markers and examine their use in breast cancer patients. The authors cover both the major advances in sophisticated molecular methods and the state-of-the-art in conventional prognostic and predictive indicators. Among the topics discussed are the relevance of rigorous study design and guidelines for the validation studies of new biomarkers, gene expression profiling by tissue microarrays, adjuvant systemic therapy, and the use of estrogen, progesterone, and epidermal growth factor receptors as both prognostic and predictive indicators. Highlights include the evaluation of HER2 and EGFR family members, of p53, and of UPA/PAI-1; the detection of rare cells in blood and marrow; and the detection and analysis of soluble, circulating markers.

"synopsis" may belong to another edition of this title.

From the Back Cover:

It is now well recognized that individualized cancer treatment planning, based on tumor characteristics specific to an individual's cancer, makes it easier to select those most likely to benefit from toxic cancer therapies and to avoid treating those least likely to benefit. In Biomarkers in Breast Cancer: Molecular Diagnostics for Predicting and Monitoring Therapeutic Effect, expert laboratory and clinical researchers from around the world review how to design and evaluate studies of tumor markers, as well as examine their use in breast cancer patients. The authors cover both the major advances in sophisticated molecular methods and the state-of-the-art in conventional prognostic and predictive indicators. Among the topics discussed are the relevance of rigorous study design and guidelines to the validation of new biomarkers, gene expression profiling by tissue microarrays, adjuvant systemic therapy, and the use of estrogen, progesterone, and epidermal growth factor receptors as both prognostic and predictive indicators. Highlights include the evaluation of HER2 and EGFR family members, of p53, and of UPA/PAI-1; the detection of rare cells in blood and marrow; and the detection and analysis of soluble, circulating markers.
Authoritative and cutting-edge, Biomarkers in Breast Cancer: Molecular Diagnostics for Predicting and Monitoring Therapeutic Effect offers laboratory investigators developing new tumor markers, clinical investigators testing them, and clinicians using them an up-to-date understanding of both the prognostic/predictive indicators and the novel molecular-targeted therapies suitable for individualizing breast cancer therapy.

"About this title" may belong to another edition of this title.

Buy New View Book
List Price: US$ 279.99
US$ 387.95

Convert currency

Shipping: FREE
From United Kingdom to U.S.A.

Destination, rates & speeds

Add to Basket

Other Popular Editions of the Same Title

9781588292278: Biomarkers in Breast Cancer (Cancer Drug Discovery and Development)

Featured Edition

ISBN 10:  1588292274 ISBN 13:  9781588292278
Publisher: Humana Press, 2005
Hardcover

Top Search Results from the AbeBooks Marketplace

1.

Published by Humana Press Inc., United States (2010)
ISBN 10: 1617374369 ISBN 13: 9781617374364
New Paperback Quantity Available: 10
Seller:
The Book Depository
(London, United Kingdom)
Rating
[?]

Book Description Humana Press Inc., United States, 2010. Paperback. Condition: New. Language: English. Brand new Book. Expert laboratory and clinical researchers from around the world review how to design and evaluate studies of tumor markers and examine their use in breast cancer patients. The authors cover both the major advances in sophisticated molecular methods and the state-of-the-art in conventional prognostic and predictive indicators. Among the topics discussed are the relevance of rigorous study design and guidelines for the validation studies of new biomarkers, gene expression profiling by tissue microarrays, adjuvant systemic therapy, and the use of estrogen, progesterone, and epidermal growth factor receptors as both prognostic and predictive indicators. Highlights include the evaluation of HER2 and EGFR family members, of p53, and of UPA/PAI-1; the detection of rare cells in blood and marrow; and the detection and analysis of soluble, circulating markers. Softcover reprint of hardcover 1st ed. 2006. Seller Inventory # AAV9781617374364

More information about this seller | Contact this seller

Buy New
US$ 387.95
Convert currency

Add to Basket

Shipping: FREE
From United Kingdom to U.S.A.
Destination, rates & speeds

2.

Published by Humana Press (2010)
ISBN 10: 1617374369 ISBN 13: 9781617374364
New Paperback Quantity Available: 2
Seller:
Revaluation Books
(Exeter, United Kingdom)
Rating
[?]

Book Description Humana Press, 2010. Paperback. Condition: Brand New. reprint edition. 360 pages. 9.02x5.98x0.81 inches. In Stock. Seller Inventory # x-1617374369

More information about this seller | Contact this seller

Buy New
US$ 384.14
Convert currency

Add to Basket

Shipping: US$ 9.90
From United Kingdom to U.S.A.
Destination, rates & speeds

3.

Published by Humana Press Inc., United States (2010)
ISBN 10: 1617374369 ISBN 13: 9781617374364
New Paperback Quantity Available: 10
Seller:
Book Depository International
(London, United Kingdom)
Rating
[?]

Book Description Humana Press Inc., United States, 2010. Paperback. Condition: New. Language: English. Brand new Book. Expert laboratory and clinical researchers from around the world review how to design and evaluate studies of tumor markers and examine their use in breast cancer patients. The authors cover both the major advances in sophisticated molecular methods and the state-of-the-art in conventional prognostic and predictive indicators. Among the topics discussed are the relevance of rigorous study design and guidelines for the validation studies of new biomarkers, gene expression profiling by tissue microarrays, adjuvant systemic therapy, and the use of estrogen, progesterone, and epidermal growth factor receptors as both prognostic and predictive indicators. Highlights include the evaluation of HER2 and EGFR family members, of p53, and of UPA/PAI-1; the detection of rare cells in blood and marrow; and the detection and analysis of soluble, circulating markers. Softcover reprint of hardcover 1st ed. 2006. Seller Inventory # AAV9781617374364

More information about this seller | Contact this seller

Buy New
US$ 395.79
Convert currency

Add to Basket

Shipping: FREE
From United Kingdom to U.S.A.
Destination, rates & speeds

4.

Published by Humana Press (2010)
ISBN 10: 1617374369 ISBN 13: 9781617374364
New Softcover Quantity Available: 1
Seller:
Irish Booksellers
(Portland, ME, U.S.A.)
Rating
[?]

Book Description Humana Press, 2010. Condition: New. book. Seller Inventory # M1617374369

More information about this seller | Contact this seller

Buy New
US$ 414.09
Convert currency

Add to Basket

Shipping: US$ 3.27
Within U.S.A.
Destination, rates & speeds

5.

Humana Press
Published by Humana Press (2010)
ISBN 10: 1617374369 ISBN 13: 9781617374364
New Paperback Quantity Available: 1
Seller:
Books Express
(Portsmouth, NH, U.S.A.)
Rating
[?]

Book Description Humana Press, 2010. Paperback. Condition: New. Ships with Tracking Number! INTERNATIONAL WORLDWIDE Shipping available. Buy with confidence, excellent customer service! Softcover reprint of hardcover 1st ed. 2006. Seller Inventory # 1617374369n

More information about this seller | Contact this seller

Buy New
US$ 497.72
Convert currency

Add to Basket

Shipping: FREE
Within U.S.A.
Destination, rates & speeds